Joseph Kulkosky

3.6k total citations
40 papers, 3.1k citations indexed

About

Joseph Kulkosky is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Joseph Kulkosky has authored 40 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Virology, 24 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Joseph Kulkosky's work include HIV Research and Treatment (35 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (9 papers). Joseph Kulkosky is often cited by papers focused on HIV Research and Treatment (35 papers), HIV/AIDS drug development and treatment (22 papers) and HIV/AIDS Research and Interventions (9 papers). Joseph Kulkosky collaborates with scholars based in United States. Joseph Kulkosky's co-authors include Richard A. Katz, Anna Marie Skalka, Joseph P. G. Mack, Roger J. Pomerantz, Kathryn S. Jones, A M Skalka, George Merkel, Yan Xu, Julie Sullivan and Jonathan Leis and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Joseph Kulkosky

40 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joseph Kulkosky United States 26 2.2k 1.7k 1.4k 594 408 40 3.1k
Vinayaka R. Prasad United States 31 1.9k 0.9× 1.6k 0.9× 1.4k 1.0× 226 0.4× 366 0.9× 91 2.9k
Masahiro Yamashita Japan 24 1.5k 0.7× 922 0.5× 1.0k 0.7× 1.1k 1.8× 451 1.1× 59 2.9k
Zene Matsuda Japan 24 1.1k 0.5× 1.1k 0.7× 689 0.5× 402 0.7× 458 1.1× 47 2.3k
Lionel Berthoux Canada 24 1.4k 0.6× 576 0.3× 931 0.6× 711 1.2× 494 1.2× 54 2.1k
Timothy W. Baba United States 21 2.4k 1.1× 982 0.6× 676 0.5× 1.5k 2.5× 1.0k 2.5× 33 3.2k
Shinji Harada Japan 26 1.8k 0.8× 1.2k 0.7× 525 0.4× 1.5k 2.5× 583 1.4× 100 3.1k
Shuyi Wang United States 17 2.1k 1.0× 1.1k 0.6× 888 0.6× 1.2k 2.0× 760 1.9× 35 3.3k
Charles E. Buckler United States 34 1.1k 0.5× 635 0.4× 928 0.6× 1.3k 2.3× 744 1.8× 76 3.1k
W G Robey United States 22 1.5k 0.7× 639 0.4× 518 0.4× 978 1.6× 488 1.2× 44 2.1k
Clotilde Thiriart Belgium 18 1.2k 0.5× 567 0.3× 645 0.4× 660 1.1× 556 1.4× 23 2.0k

Countries citing papers authored by Joseph Kulkosky

Since Specialization
Citations

This map shows the geographic impact of Joseph Kulkosky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Kulkosky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Kulkosky more than expected).

Fields of papers citing papers by Joseph Kulkosky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Kulkosky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Kulkosky. The network helps show where Joseph Kulkosky may publish in the future.

Co-authorship network of co-authors of Joseph Kulkosky

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Kulkosky. A scholar is included among the top collaborators of Joseph Kulkosky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Kulkosky. Joseph Kulkosky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nunnari, Giuseppe, Julie Sullivan, Yan Xu, et al.. (2005). HIV Type 1 Cervicovaginal Reservoirs in the Era of HAART. AIDS Research and Human Retroviruses. 21(8). 714–718. 25 indexed citations
2.
Nunnari, Giuseppe, et al.. (2005). Short Communication: Seminal Reservoirs during an HIV Type 1 Eradication Trial. AIDS Research and Human Retroviruses. 21(9). 768–775. 20 indexed citations
3.
Daniel, René, Joseph Kulkosky, Konstantin D. Taganov, et al.. (2004). Characterization of a Naphthalene Derivative Inhibitor of Retroviral Integrases. AIDS Research and Human Retroviruses. 20(2). 135–144. 6 indexed citations
4.
Kulkosky, Joseph, Julie Sullivan, Yan Xu, et al.. (2004). Expression of Latent HAART-Persistent HIV Type 1 Induced by Novel Cellular Activating Agents. AIDS Research and Human Retroviruses. 20(5). 497–505. 47 indexed citations
5.
Argyris, Elias G., Joseph Kulkosky, Yan Xu, et al.. (2004). The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity. Virology. 330(2). 481–486. 23 indexed citations
6.
Xu, Yan, Joseph Kulkosky, Edward Acheampong, et al.. (2004). HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathy. Proceedings of the National Academy of Sciences. 101(18). 7070–7075. 87 indexed citations
7.
Otero, Miguel, Giuseppe Nunnari, Julie Sullivan, et al.. (2003). Peripheral Blood Dendritic Cells Are Not a Major Reservoir for HIV Type 1 in Infected Individuals on Virally Suppressive HAART. AIDS Research and Human Retroviruses. 19(12). 1097–1103. 45 indexed citations
8.
Kulkosky, Joseph, Julie Sullivan, Yan Xu, et al.. (2003). Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo. Virology. 314(2). 617–629. 13 indexed citations
9.
Mascio, Michele Di, Geethanjali Dornadula, Hui Zhang, et al.. (2003). In a Subset of Subjects on Highly Active Antiretroviral Therapy, Human Immunodeficiency Virus Type 1 RNA in Plasma Decays from 50 to <5 Copies per Milliliter, with a Half-Life of 6 Months. Journal of Virology. 77(3). 2271–2275. 50 indexed citations
10.
Kulkosky, Joseph & Roger J. Pomerantz. (2002). Approaching Eradication of Highly Active Antiretroviral Therapy–Persistent Human Immunodeficiency Virus Type 1 Reservoirs with Immune Activation Therapy. Clinical Infectious Diseases. 35(12). 1520–1526. 31 indexed citations
11.
Kulkosky, Joseph, Giuseppe Nunnari, Miguel Otero, et al.. (2002). Intensification and Stimulation Therapy for Human Immunodeficiency Virus Type 1 Reservoirs in Infected Persons Receiving Virally Suppressive Highly Active Antiretroviral Therapy. The Journal of Infectious Diseases. 186(10). 1403–1411. 112 indexed citations
12.
Patel, Charvi, et al.. (2002). Lentiviral expression of HIV-1 Vpr induces apoptosis in human neurons. Journal of NeuroVirology. 8(2). 86–99. 47 indexed citations
13.
Kulkosky, Joseph, Derek M. Culnan, Jeanette Roman, et al.. (2001). Prostratin: activation of latent HIV-1 expression suggests a potential inductive adjuvant therapy for HAART. Blood. 98(10). 3006–3015. 282 indexed citations
14.
Kulkosky, Joseph, et al.. (2000). Pathogenesis of HIV-1 Infection Within Bone Marrow Cells. Leukemia & lymphoma. 37(5-6). 497–515. 25 indexed citations
15.
Kulkosky, Joseph, Alexey V. Laptev, Alagarsamy Srinivasan, et al.. (1999). Human Immunodeficiency Virus Type 1 Vpr Alters Bone Marrow Cell Function. Blood. 93(6). 1906–1915. 22 indexed citations
16.
Kulkosky, Joseph, et al.. (1999). A Novel Vpr Peptide Interactor Fused to Integrase (IN) Restores Integration Activity to IN-Defective HIV-1 Virions. Virology. 255(1). 77–85. 10 indexed citations
17.
Kulkosky, Joseph, et al.. (1994). Monoclonal Antibodies against HIV Type 1 Integrase: Clues to Molecular Structure. AIDS Research and Human Retroviruses. 10(9). 1105–1115. 46 indexed citations
18.
Kulkosky, Joseph & Anna Marie Skalka. (1994). Molecular mechanism of retroviral DNA integration. Pharmacology & Therapeutics. 61(1-2). 185–203. 44 indexed citations
19.
Katz, Richard A., Joseph P. G. Mack, G. Merkel, et al.. (1992). Requirement for a conserved serine in both processing and joining activities of retroviral integrase.. Proceedings of the National Academy of Sciences. 89(15). 6741–6745. 31 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vinayaka R. Prasad Breakdown of academic impact, for papers by Masahiro Yamashita Breakdown of academic impact, for papers by Zene Matsuda Breakdown of academic impact, for papers by Lionel Berthoux Breakdown of academic impact, for papers by Timothy W. Baba Breakdown of academic impact, for papers by Shinji Harada Breakdown of academic impact, for papers by Shuyi Wang Breakdown of academic impact, for papers by Charles E. Buckler Breakdown of academic impact, for papers by W G Robey Breakdown of academic impact, for papers by Clotilde Thiriart
Rankless by CCL
2026